Valuation : PAVmed Inc.

Market Cap 36.92M 31.77M 29.89M 27.31M 51.08M 3.49B 51.22M 353M 137M 1.79B 139M 136M 5.76B P/E 2026 *
-1.46x
P/E 2027 * -2.67x
Enterprise Value 36.92M 31.77M 29.89M 27.31M 51.08M 3.49B 51.22M 353M 137M 1.79B 139M 136M 5.76B EV / Sales 2026 *
159x
EV / Sales 2027 * 61.5x
Free-Float
58.56%
Yield 2026 *
-
Yield 2027 * -
1 day+3.73%
1 week+7.32%
Current month+1.34%
1 month+6.88%
3 months-3.12%
6 months-49.33%
Current year-20.29%
1 week 4.9
Extreme 4.9
5.65
1 month 4.19
Extreme 4.19
5.65
Current year 3.85
Extreme 3.85
28.44
1 year 3.85
Extreme 3.85
28.44
3 years 3.85
Extreme 3.85
270
5 years 3.85
Extreme 3.85
4,365
10 years 3.85
Extreme 3.85
6,502.5
Manager TitleAgeSince
Compliance Officer 62 31/03/2023
Chief Executive Officer 60 25/06/2014
Director of Finance/CFO 68 28/02/2019
Director TitleAgeSince
Director/Board Member 60 30/09/2014
Chairman 60 25/06/2014
Director/Board Member 71 31/12/2014
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/26 Free

Chief Technology Officer

70,000 1.0966%
02/04/26 Free

Chief Operating Officer

110,000 1.7233%
02/04/26 Free

Chief Executive Officer

350,000 5.4832%
Change 5-day change 1-year change 3-year change Capi.($)
+3.73%+7.32%-60.49%-97.24% 36.92M
-0.75%-1.35%+24.60%+14.36% 227B
-1.60%-3.89%+3.72%-19.20% 146B
-0.85%-1.58%-21.45%+19.12% 130B
+1.81%+2.05%-55.42%-11.25% 69.27B
+0.13%-0.34%+11.07%+16.81% 51.82B
-1.64%-1.69%-19.08%-15.41% 50.45B
+0.59%-1.94%+17.17%+27.91% 42.53B
-1.01%-1.28%+33.64%+50.03% 40.22B
-1.55%+1.22%+120.58%+36.40% 32.95B
Average -0.11%-0.11%+5.43%+2.15% 78.98B
Weighted average by Cap. -0.67%-1.41%+6.55%+8.41%

Financials

2026 *2027 *
Net sales 232K 200K 188K 172K 322K 21.95M 323K 2.22M 863K 11.26M 873K 854K 36.28M 600K 516K 486K 444K 830K 56.65M 832K 5.74M 2.23M 29.07M 2.25M 2.2M 93.63M
Net income -23.17M -19.94M -18.76M -17.14M -32.06M -2.19B -32.15M -222M -86.03M -1.12B -87.02M -85.12M -3.62B -20.15M -17.34M -16.31M -14.9M -27.88M -1.9B -27.95M -193M -74.8M -976M -75.66M -74.01M -3.14B
Net Debt - -
Logo PAVmed Inc.
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.
Employees
41
Date Price Change Volume
04/09/26 US$5.280 +3.73% 66,489
03/09/26 US$5.090 -4.86% 5,746
02/09/26 US$5.350 +7.21% 7,002
01/09/26 US$4.990 -4.22% 4,211
31/08/26 US$5.210 +5.89% 31,436
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.280USD
Average target price
36.50USD
Spread / Average Target
+591.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PAVM Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!